Industry experts discuss the current state of the immune category, emerging research to note, and a look at what’s to come as ...

Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...

Tonix Pharma announces US commercial availability of Tonmya as a first-in-class fibromyalgia treatment: Chatham, New Jersey Thursday, November 20, 2025, 17:00 Hrs [IST] Tonix Phar ...

Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...

Congress has enacted sweeping changes to the hemp framework established by the 2018 Farm Bill that will materially affect hemp and ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

Viking Therapeutics is a clinical-stage biopharmaceutical company that specializes in developing novel therapies for metabolic and endocrine disorders. Here's what investors should know.

When we do things like quantum calculations, we look at the confirmer space. So what that does is give us insight into how a ...

PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in ...

Avicanna (AVCNF) announced preclinical results and the filing of a provisional patent application with the United States Patent and Trademark Office for its Powder Drug Delivery System platform. The ...

Jefferies London Healthcare Conference 2025 November 19, 2025 3:00 AM ESTCompany ParticipantsBrian Lian - President, ...

Valued at USD 4.6 billion in 2025, the market is projected to reach USD 8.2 billion by 2035, reflecting a steady 5.9% CAGR. Sorbitol remains the highest-volume segment with a 25% revenue share, while ...